ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New

ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD)

ANANDA Scientific

Google Pilots Opioid Addiction Moonshot in Dayton, Ohio - Bloomberg

ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)

ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD) - 뉴스와이어

ANANDA Scientific

Sohail R. Zaidi posted on LinkedIn

VEGANZONE Will Grow Vegan Community in 196 Countries! - AETOSWire

ANANDA Scientific Announces First Patient Enrolled in the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

MJBizMagazine July 2022 by MJBiz Daily - Issuu

Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs - ScienceDirect

Assessing and Treating Opioid Use Disorder in Pregnancy

A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions

Ananda Scientific (@AnandaScience) / X